The Centers for Disease Control and Prevention (CDC) has awarded a single award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $149,625,000 and a period of performance from the date of award through February 28, 2023.
Under this IDC, Sanofi Pasteur Inc. will provide between 100 and 50 million doses of pediatric influenza vaccine, which will be delivered to CDC distribution centers in Colorado and Tennessee. The vaccines are intended to support pediatric immunization programs conducted by the CDC's National Center for Immunization and Respiratory Diseases, including the Section 317(j) and Vaccine for Children (VFC) programs. Sanofi Pasteur Inc., as the prime contractor, will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill the CDC's vaccine requirements on a firm fixed price basis with no set-aside designation.
Generated 8/30/24, 6:19 PM